First-line systemic therapy in patients with metastatic or locally advanced urothelial carcinoma: a systematic review and network meta-analysis of randomized controlled trials

Background: The emergence of immune checkpoint inhibitors and antibody–drug conjugates has revolutionized the first-line treatment landscape for locally advanced or metastatic urothelial carcinoma (la/mUC). However, the optimal treatment strategy remains uncertain. Objectives: This network meta-anal...

Full description

Bibliographic Details

Published in:	Therapeutic Advances in Medical Oncology
Main Authors:	Yandong Xie, Haoyang Liu, Yanfeng Tang, Yaowen Zhang, Nanwei Xu, Fengnian Zhao, Jinge Zhao, Guangxi Sun, Zhenhua Liu, Pengfei Shen, Hao Zeng, Junru Chen
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-07-01
Online Access:	https://doi.org/10.1177/17588359251357527